Difference between revisions of "Pracinostat (SB-939)"
Jump to navigation
Jump to search
(Created page with "=Mechanism of action= HDAC inhibitor =History of changes in FDA indication= *2/27/2014: Granted FDA orphan drug status for treatment of [[Acute myeloid leukemia | acute myelo...") |
Warner-admin (talk | contribs) m (Warner-admin moved page Pracinostat (SB939) to Pracinostat (SB-939) without leaving a redirect) |
||
| (10 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| − | =Mechanism of action= | + | ==Mechanism of action== |
HDAC inhibitor | HDAC inhibitor | ||
| − | = | + | ==Also known as== |
| − | * | + | *'''Code name:''' SB-939 |
| − | [[Category: | + | [[Category:Drugs]] |
| + | [[Category:Oral medications]] | ||
| − | |||
[[Category:HDAC inhibitors]] | [[Category:HDAC inhibitors]] | ||
| − | [[Category:Acute myeloid leukemia medications]] | + | [[Category:Acute myeloid leukemia medications (investigational)]] |
| + | |||
| + | [[Category:Investigational drugs]] | ||
| + | [[Category:Stub]] | ||
Latest revision as of 00:38, 29 July 2023
Mechanism of action
HDAC inhibitor
Also known as
- Code name: SB-939